Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication

被引：25
|
作者：
Dorr, Casey R. [1 ]
Yemets, Sergiy [2 ]
Kolomitsyna, Oksana [2 ]
Krasutsky, Pavel [2 ]
Mansky, Louis M. [1 ]
机构：
[1] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Nat Resources Res Inst, Duluth, MN 55811 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 01期
关键词：
Retrovirus; Antiviral; Antiretroviral; Proteolysis; Protease; BETULINIC ACID; HIV-1; MATURATION; RESISTANCE; BEVIRIMAT; PA-457; STEP;
D O I：
10.1016/j.bmcl.2010.10.078
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Triterpene derivatives were analyzed for anti-HIV-1 activity and for cellular toxicity. Betulinic aldehyde, betulinic nitrile, and morolic acid derivatives were identified to have anti-HIV-1 activity. These derivatives inhibit a late step in virus replication, likely virus maturation. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：542 / 545
页数：4
相关论文
共 50 条
  • [41] ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TARGETED TO THE VPR GENE INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY HUMAN MACROPHAGES
    BALOTTA, C
    LUSSO, P
    CROWLEY, R
    GALLO, RC
    FRANCHINI, G
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (07) : 4409 - 4414
  • [42] Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
    Srinivas, RV
    Ray, RB
    Meyer, K
    Ray, R
    [J]. VIRUS RESEARCH, 1996, 45 (02) : 87 - 92
  • [43] Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription
    Kutsch, O
    Levy, DN
    Bates, PJ
    Decker, J
    Kosloff, BR
    Shaw, GM
    Priebe, W
    Benveniste, EN
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) : 1652 - 1663
  • [44] Dicaffeoyltartaric acid analogues inhibit human immunodeficiency virus type 1 (HIV-1) integrase and HIV-1 replication at nontoxic concentrations
    Reinke, RA
    King, PJ
    Victoria, JG
    McDougall, BR
    Ma, GX
    Mao, YQ
    Reinecke, MG
    Robinson, WE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) : 3669 - 3683
  • [45] Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide
    Jiménez, JL
    González-Nicolás, J
    Alvarez, S
    Fresno, M
    Muñoz-Fernández, MA
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (10) : 4655 - 4663
  • [46] Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat
    Barthelemy, S
    Vergnes, L
    Moynier, M
    Guyot, D
    Labidalle, S
    Bahraoui, E
    [J]. RESEARCH IN VIROLOGY, 1998, 149 (01): : 43 - 52
  • [47] Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1
    Lai, Weihong
    Huang, Li
    Ho, Phong
    Li, Zhijun
    Montefiori, David
    Chen, Chin-Ho
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) : 128 - 136
  • [48] Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1
    Keppler, OT
    Yonemoto, W
    Welte, FJ
    Patton, KS
    Iacovides, D
    Atchison, RE
    Ngo, T
    Hirschberg, DL
    Speck, RF
    Goldsmith, MA
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (17) : 8063 - 8073
  • [49] Characterizing the antiviral effect of an ATR inhibitor on human immunodeficiency virus type 1 replication
    Docando, Felix
    Casado, Concepcion
    Pernas, Maria
    Mota-Biosca, Anna
    Lopez-Galindez, Cecilio
    Olivares, Isabel
    [J]. ARCHIVES OF VIROLOGY, 2020, 165 (03) : 683 - 690
  • [50] Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication
    Hung, M
    Patel, P
    Davis, S
    Green, SR
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (06) : 4819 - 4824
12345